Frequent mutations and loss of expression of E-cadherin have been reported in a number of cancers. E-cadherin germ line mutations lead to a high risk of familial diffused gastric carcinoma. In the present study, to evaluate the effect of genetic polymorphisms in the E-cadherin promoter on the risk of sporadic gastric carcinoma (SGC), a comprehensive study was conducted in two populations with high and low risk of SGC in China, respectively. Five hundred seventy-two SGC cases and 625 controls from low-risk area and 589 individuals enrolled in a long-term follow-up survey in high-risk area were studied. Polymorphisms of E-cadherin around transcription start site (−437 to +314) were analyzed by sequencing. Five variations of −347del>A, −160C>A, −73A>C, +178T>C, and +234 13N ins>del were linked tightly. The −347del/del and its strongly linked +178T/T, +234 13N ins/ins genotypes increased male SGC risk in the high-risk area significantly [odds ratio (OR), 2.22; 95% confidence intervals (95% CI), 1.10-4.46] and correlated with the severity of gastric lesions. A synergetic effect was also observed between −347del/del genotype and Helicobacter pylori infection (OR, 4.93; 95% CI, 1.65-14.71). Compared with −347del-containing haplotypes, the −347A-containing haplotype [A(−347)-C(−160)-A(−73)-C(+178)-13N del(+234)] decreased the risk of SGC among male subjects (OR, 0.61; 95% CI, 0.37-1.01). Such correlation could not be observed among subjects from the low-risk area. The present data suggest that the −347del allele of E-cadherin strongly links with the +178T and +234 13N ins alleles. The −347del/del genotype may increase the susceptibility of SGC among males in the high-risk area of China. (Cancer Epidemiol Biomarkers Prev 2008;17(9):2402–8)

Stomach cancer is still one of the leading causes of cancer death in China (1). The possible etiologic factors for sporadic gastric carcinoma (SGC) include Helicobacter pylori (H. pylori) infection, high salt intake, endogenous formation of N-nitroso compounds, and malnutrition of antioxidants (2-5). Genetic susceptibility is another kind of factor that may interact with environmental factors and determine whether a subject is sensitive or resistant to the causal factors at natural level.

E-cadherin is an epithelial cell-cell adhesive molecule (6). Inactivation of the E-cadherin by germ line mutations is observed frequently in patients with familial gastric carcinomas (7, 8). Somatic E-cadherin mutations are common in diffused-type SGC and infiltrative lobular breast carcinoma (9, 10) but rare in other sporadic carcinomas (11-13). Down-regulation of the E-cadherin is much more frequent than somatic mutation in many sporadic human carcinomas in various organs such as stomach, colon, pancreas, breast, and prostate (14-18). Methylation of CpG island of the E-cadherin and up-regulation of transcriptional repressors such as SNAIL might account for most of lost transcription of the E-cadherin in sporadic carcinomas finally (19-21).

There are a number of polymorphisms clustered around the transcription start site (TSS) of the E-cadherin gene (Fig. 1). It was reported that single nucleotide polymorphisms (SNP) −160C>A (rs16260) and −347del>A (rs5030625) in the promoter might alter the transcriptional activity of this gene's promoter (22, 23), which attracted a lot of attentions to investigate the possible effects of these polymorphisms on the susceptibility of SGC and other cancers (24-29). However, results of these association studies were not consistent or even contradictory. In the present study, we reported a comprehensive analysis of these variations and haplotypes of the E-cadherin promoter and their correlation with the SGC risk in two populations with high and low risk of SGC in China, respectively, examining the effect of genetic factors to SGC under different environmental pressure. The transcriptional activity of the promoter with different haplotypes was also studied.

Figure 1.

Information of variations in the E-cadherin promoter and downstream region. The position +1 refer to TSS. Dark boxes, Sp1 binding sites; gray box, CAAT box; unfilled boxes, E-boxes. The variation rs number was from the National Center for Biotechnology Information SNP database (http://www.ncbi.nlm.nih.gov/SNP/). rs3833051 is a polymorphism of 13 bp (CGTGCCCCAGCCC) insertion (13N ins) or deletion (13N del). Six variations detected in the present study were underlined. Arrows, locations of two PCR primer sets used in the present study.

Figure 1.

Information of variations in the E-cadherin promoter and downstream region. The position +1 refer to TSS. Dark boxes, Sp1 binding sites; gray box, CAAT box; unfilled boxes, E-boxes. The variation rs number was from the National Center for Biotechnology Information SNP database (http://www.ncbi.nlm.nih.gov/SNP/). rs3833051 is a polymorphism of 13 bp (CGTGCCCCAGCCC) insertion (13N ins) or deletion (13N del). Six variations detected in the present study were underlined. Arrows, locations of two PCR primer sets used in the present study.

Close modal

Study Populations

Subjects from Linqu County. Linqu County is a rural area in Shandong province in northeast China and a high-risk area for stomach cancer, where the world age-adjusted incidence of stomach cancer from 1993 to 1997 was 73.2 per year per 100,000 males according to China Cancer Database4 and adult chronic atrophic gastritis (CAG) was nearly universal (98%; ref. 30). Genomic DNA of subjects with different gastric lesions, including CAG (n = 196), intestinal metaplasia/gastric dysplasia (IM/DYS; n = 197), and SGC (n = 96), was isolated from peripheral blood samples. As shown in Table 1, information on status of pathologic changes of gastric mucosa (diagnosed by a panel of three senior pathologists of Peking University School of Oncology), H. pylori infection (measured by ELISA; ref. 31), alcohol drinking, and smoking was available for these analyzed subjects who enrolled in a 20-year gastroendoscopy follow-up survey.

Table 1.

Information of age, sex, and selected risk factors for subjects from the high-SGC-risk area Linqu and low-SGC-risk area Beijing

VariableLinqu
Beijing
CAG* (n = 196)IM/DYS (n = 197)SGC (n = 96)Control* (n = 625)SGC (n = 572)
Mean age ± SD 55.4 ± 7.3 55.8 ± 8.6 59.2 ± 9.4 61.3 ± 11.9 58.4 ± 12.1 
    P  0.637 <0.001  <0.001 
Sex (%)      
    Male 99 (50.5) 98 (49.7) 76 (79.2) 384 (61.4) 404 (70.6) 
    Female 97 (49.5) 99 (50.3) 20 (20.8) 241 (38.6) 168 (29.4) 
    P  0.880 <0.001  0.001 
H. pylori infection (%) (n = 192) (n = 197) (n = 96)   
    Yes 131 (68.2) 155 (78.7) 78 (81.3)   
    No 61 (31.8) 42 (21.3) 18 (18.8)   
    P  0.020 0.020   
Smoking status (%) (n = 192) (n = 196) (n = 96)   
    Yes 83 (42.3) 89 (45.4) 66 (68.8)   
    No 109 (55.6) 107 (54.6) 30 (31.3)   
    P  0.666 <0.001   
Alcohol drinking (%) (n = 191) (n = 196) (n = 96)   
    Yes 88 (46.1) 84 (42.9) 62 (64.6)   
    No 103 (53.9) 112 (57.1) 34 (35.4)   
    P  0.524 0.003   
VariableLinqu
Beijing
CAG* (n = 196)IM/DYS (n = 197)SGC (n = 96)Control* (n = 625)SGC (n = 572)
Mean age ± SD 55.4 ± 7.3 55.8 ± 8.6 59.2 ± 9.4 61.3 ± 11.9 58.4 ± 12.1 
    P  0.637 <0.001  <0.001 
Sex (%)      
    Male 99 (50.5) 98 (49.7) 76 (79.2) 384 (61.4) 404 (70.6) 
    Female 97 (49.5) 99 (50.3) 20 (20.8) 241 (38.6) 168 (29.4) 
    P  0.880 <0.001  0.001 
H. pylori infection (%) (n = 192) (n = 197) (n = 96)   
    Yes 131 (68.2) 155 (78.7) 78 (81.3)   
    No 61 (31.8) 42 (21.3) 18 (18.8)   
    P  0.020 0.020   
Smoking status (%) (n = 192) (n = 196) (n = 96)   
    Yes 83 (42.3) 89 (45.4) 66 (68.8)   
    No 109 (55.6) 107 (54.6) 30 (31.3)   
    P  0.666 <0.001   
Alcohol drinking (%) (n = 191) (n = 196) (n = 96)   
    Yes 88 (46.1) 84 (42.9) 62 (64.6)   
    No 103 (53.9) 112 (57.1) 34 (35.4)   
    P  0.524 0.003   
*

CAG and control as a reference group for SGC cases from Linqu and Beijing, respectively.

Subjects from Beijing. Beijing is a low-risk area for stomach cancer in China, where the world age-adjusted incidence of stomach cancer from 1993 to 1997 was 19.8 per year per 100,000 males.4

Genomic DNA was extracted from the frozen surgical adjacent gross pathologic normal gastric tissue of SGC from cases (n = 572) diagnosed and treated surgically at Peking University School of Oncology. Clinical pathologic information was available for all 572 SGC cases. Blood DNA samples of nonmalignant controls (n = 625) were obtained from Peking University First Hospital.

The study was approved by the institutional review board of Peking University School of Oncology, and all subjects gave written informed consent.

Amplification and Sequencing of the E-Cadherin Promoter

The forward and reverse genotyping primers for the TSS flanking region (−437 to +314; Fig. 1) of E-cadherin (Genbank accession number gi:18057085) are 5′-CTGGGGCCAGAGGACCGCTTGA-3′ and 5′-CTTCCAGGCCGCTCCGCTCCT-3′, respectively. The PCR amplification was carried out in a final volume of 40 μL containing 50 ng genomic DNA, 0.2 mmol/L deoxynucleotide triphosphate, 0.2 μmol/L of each primer, 0.5 units plaque-forming unit DNA polymerase (Sangon Company), using the touchdown PCR protocol: 95°C for 5 min→(95°C for 30 s→70°C for 30 s, −1°C/cycle→72°C for 30 s) × 12 cycles→(95°C for 30 s→58°C for 30 s→72°C for 30 s) × 28 cycles →72°C for 10 min in PTC-200 DNA Engine (MJ Research, Inc.). The PCR product (752 bp) was directly sequenced with ABI 3730 DNA sequencer. The genotypes of representative samples were verified by cloning sequencing.

PCR-RFLP Analysis

As the −347del/A heterozygote may affect the resolution of +178 genotype due to the long distance between these two sites, the genotype of +178T>C SNP was further confirmed by PCR-RFLP analysis, in which the 100 bp sequence (+124-+223) was amplified by PCR using the primers 5′-CATGGGCCCTTGGAGCCGCAG-3′ and 5′-CGGAGCTTGCGGCCCGAATG-3′ with thermal cycle condition [95°C for 5 min→(95°C for 30 s→70°C for 30 s, −1°C/cycle→72°C for 30 s) × 12 cycles→(95°C for 30 s→58°C for 30 s→72°C for 30 s) × 28 cycles→72°C for 10 min] and digested with MspI (New England Biolab) followed by separating on 10% polyacrylamide gel (PAGE).

Dual-Luciferase Reporter Assay

To determine the effect of these variations on transcriptional activity of the E-cadherin promoter, the same fragment (−437 to +314) carrying all these variations was amplified from the tested samples with expected genotypes. The reporter primers were the same as the above genotyping primers, except that each of them contained a NheI and a HindIII site introduced to the 5′ end, respectively. The PCR products were digested with NheI and HindIII (New England Biolab) and then cloned into pGL3-Basic vector (Genbank accession number U47295; Promega), which does not contain promoter and enhancer sequences. Two luciferase reporter plasmids were generated: the pGL-H1 with the haplotype H1 [del-C-A-T-CGTGCCCCAGCCC (13N) ins] and the pGL-H4 with [A-C-A-C-13N del]. Each construct was confirmed by sequencing. Plasmid DNA was obtained by transforming the vectors into JM 109 bacteria and subsequent large-scale plasmid preparation with Qiagen Plasmid Midi Kit (Qiagen).

MCF7, HeLa cell lines cultured in DMEM, and MKN74 cell line cultured in RPMI 1640 (Life Technologies) were used. Transient transfections were done with Lipofectamine 2000 reagent (Invitrogen) after the cells were plated into a 24-well culture plate at a density of 5 × 104 per well (three wells per plasmid) and cultured for 24 h to 80% confluence. In each experiment, three different luciferase reporter plasmids were transfected: (a) pGL-Basic, (b) pGL-H1, and (c) pGL-H4. As an internal standard, pRL-SV40 (Promega) containing the Renilla luciferase gene was cotransfected with the testing plasmids to monitor the transfection efficiency. Luciferase activity was measured with Dual-Luciferase Reporter Assay System (Promega) and a luminometer (Molecular Devices, LMAXII Microplate Reader) and normalized against the activity of the Renilla luciferase gene. Independent triplicate experiments were done for each plasmid. Statistics were done using Student's unpaired two-tailed t test.

Statistical Analysis

The observed genotype frequencies among controls and SGC cases were tested for Hardy-Weinberg equilibrium. The differences in age between control and cases with cancerous/precancerous lesions were evaluated with the t test. The Pearson's χ2 test was used to examine the differences between controls and cases in sex, H. pylori infection, smoking, and alcohol drinking. Odds ratios (OR) and corresponding 95% confidence intervals (95% CI) were calculated to quantify the association between SGC risks and various genotypes, by unconditional logistic regression, adjusting for age, H. pylori infection, smoking, and alcohol drinking. These analyses were carried out with Statistical Analysis System Software (version 8.01; SAS Institute). The linkage disequilibrium and haplotype analyses were carried out on the Web site5

(32). In the analysis of stratification, the relative excess risk of interaction = ORge − (ORg + ORe − 1) and synergy index = (ORge − 1)/[(ORg − 1) +(ORe − 1)], where ORge, ORg, and ORe refer to the OR of both genetic and environmental factors, the OR of genetic factor, and the OR of environmental factor (such as H. pylori, smoking, alcohol drinking).

Single-Locus Analysis

The frequency distribution of gender, age, H. pylori infection, cigarette smoking, and alcohol drinking for subjects from Linqu and Beijing is summarized in Table 1. Because of the differences of these factors between control and case groups, these factors were adjusted in the following statistical analysis.

Within the region (−437-+314) around the TSS (+1) of the E-cadherin, six known SNP [−347del>A (allele A proportion, 26.5%), −163T>del (0.1%), −160C>A (20.6%), −73A>C (14.8%), +178T>C (26.3%), +234CGTGCCCCAGCCC (13N) ins>del (26.5%)] were characterized among the total of 1,686 tested subjects, as underlined in Fig. 1. Because the frequency of the −163T>del was <1%, this variant was ignored in the following analysis. Linkage disequilibrium analysis showed that all variations were in strong linkage disequilibrium with each other (D′≈1), especially for −347del>A, +178T>C, and +234 13N ins>del polymorphisms (r2≈1; Supplementary Table S1). In addition, the genotypes of these variations in 23 cancer cell lines were also analyzed. A novel variant (+177C>G) was observed in six cell lines but not in the above tested subjects. The detailed genotypes of each cell line were listed in the Supplementary Table S2.

Among the subjects from the high-risk area Linqu, the −347del/del and its linked +178T/T and +234 13N ins/ins genotypes were found to be associated with the increased SGC risk significantly among male subjects (P = 0.026, two sides; OR, 2.22; 95% CI, 1.10-4.46) and correlated with the severity of gastric lesions (CAG 47.5%, IM/DYS 54.1%, SGC 65.8%; trend test, P = 0.053). However, such correlation could not be observed among female subjects from the same area. Frequency of the −347del/del genotype among subjects with intestinal type of SGCs was slightly higher than that among subjects with diffused type of SGCs but not significant (P = 0.18; Table 2).

Table 2.

Allele and genotype frequency (%) of the E-cadherin promoter polymorphisms in subjects with various gastric lesions from Linqu, a high-risk area for SGC

GenotypeTotal
Male
Female
Histotype of SGCs
CAG (n = 196)IM/DYS (n = 197)SGC (n = 96)CAG (n = 99)IM/DYS (n = 98)SGC (n = 76)CAG (n = 97)IM/DYS (n = 99)SGC (n = 20)Diffused (n = 45)Intestinal (n = 51)
−347del>A (and linked +178T>C and +234 13N ins>del           
    del/del 103 (52.6) 105 (53.3) 60 (62.5) 47 (47.5) 53 (54.1) 50 (65.8)* 56 (57.7) 52 (52.5) 10 (50.0) 25 (55.6) 35 (68.6) 
    del/A 78 (39.8) 78 (39.6) 30 (31.2) 47 (47.5) 38 (38.8) 22 (28.9) 31 (32.0) 40 (40.4) 8 (40.0) 17 (37.8) 13 (25.5) 
    A/A 15 (7.7) 14 (7.1) 6 (6.3) 5 (5.1) 7 (7.1) 4 (5.3) 10 (10.3) 7 (7.1) 2 (10.0) 3 (6.7) 3 (5.9) 
−160C>A            
    C/C 123 (62.8) 128 (65.0) 53 (55.2) 61 (61.6) 66 (67.4) 43 (56.6) 62 (63.9) 62 (62.6) 10 (50.0) 25 (55.6) 28 (54.9) 
    C/A 65 (33.2) 61 (31.0) 38 (39.6) 33 (33.3) 31 (31.6) 29 (38.2) 32 (33.0) 30 (30.3) 9 (45.0) 18 (40.0) 20 (39.2) 
    A/A 8 (4.1) 8 (4.1) 5 (5.2) 5 (5.1) 1 (1.0) 4 (5.3) 3 (3.1) 7 (7.1) 1 (5.0) 2 (4.4) 3 (5.9) 
−73A>C            
    A/A 146 (74.5) 154 (78.2) 68 (70.8) 77 (77.8) 77 (78.6) 52 (68.4) 69 (71.1) 77 (77.8) 16 (80.0) 29 (64.4) 39 (76.5) 
    A/C 47 (24.0) 36 (18.3) 27 (28.1) 21 (21.2) 18 (18.4) 23 (30.3) 26 (26.8) 18 (18.2) 4 (20.0) 16 (35.6) 11 (21.6) 
    C/C 3 (1.5) 7 (3.6) 1 (1.04) 1 (1.0) 3 (3.1) 1 (1.3) 2 (2.1) 4 (4.0) 1 (2.0) 
GenotypeTotal
Male
Female
Histotype of SGCs
CAG (n = 196)IM/DYS (n = 197)SGC (n = 96)CAG (n = 99)IM/DYS (n = 98)SGC (n = 76)CAG (n = 97)IM/DYS (n = 99)SGC (n = 20)Diffused (n = 45)Intestinal (n = 51)
−347del>A (and linked +178T>C and +234 13N ins>del           
    del/del 103 (52.6) 105 (53.3) 60 (62.5) 47 (47.5) 53 (54.1) 50 (65.8)* 56 (57.7) 52 (52.5) 10 (50.0) 25 (55.6) 35 (68.6) 
    del/A 78 (39.8) 78 (39.6) 30 (31.2) 47 (47.5) 38 (38.8) 22 (28.9) 31 (32.0) 40 (40.4) 8 (40.0) 17 (37.8) 13 (25.5) 
    A/A 15 (7.7) 14 (7.1) 6 (6.3) 5 (5.1) 7 (7.1) 4 (5.3) 10 (10.3) 7 (7.1) 2 (10.0) 3 (6.7) 3 (5.9) 
−160C>A            
    C/C 123 (62.8) 128 (65.0) 53 (55.2) 61 (61.6) 66 (67.4) 43 (56.6) 62 (63.9) 62 (62.6) 10 (50.0) 25 (55.6) 28 (54.9) 
    C/A 65 (33.2) 61 (31.0) 38 (39.6) 33 (33.3) 31 (31.6) 29 (38.2) 32 (33.0) 30 (30.3) 9 (45.0) 18 (40.0) 20 (39.2) 
    A/A 8 (4.1) 8 (4.1) 5 (5.2) 5 (5.1) 1 (1.0) 4 (5.3) 3 (3.1) 7 (7.1) 1 (5.0) 2 (4.4) 3 (5.9) 
−73A>C            
    A/A 146 (74.5) 154 (78.2) 68 (70.8) 77 (77.8) 77 (78.6) 52 (68.4) 69 (71.1) 77 (77.8) 16 (80.0) 29 (64.4) 39 (76.5) 
    A/C 47 (24.0) 36 (18.3) 27 (28.1) 21 (21.2) 18 (18.4) 23 (30.3) 26 (26.8) 18 (18.2) 4 (20.0) 16 (35.6) 11 (21.6) 
    C/C 3 (1.5) 7 (3.6) 1 (1.04) 1 (1.0) 3 (3.1) 1 (1.3) 2 (2.1) 4 (4.0) 1 (2.0) 
*

SGC versus CAG; P = 0.026; OR, 2.22; 95% CI, 1.10 to 4.46; calculated by logistic regression; adjusted for age, H. pylori infection, smoke, and drink; trend test P = 0.053.

Genotype frequencies of the −73A/C SNP were not in Hardy-Weinberg equilibrium in IM/DYS samples (P < 0.05).

The risks of SGC related to −347del/del and its linked genotypes were further examined for subjects from Linqu with stratification by H. pylori infection, cigarette smoking, and alcohol drinking (Table 3). The OR of SGC for subjects carrying the −347del/del genotype or H. pylori infection alone was 2.0 (95% CI, 0.53-7.61) or 2.35 (95% CI, 0.73-7.54), respectively. However, the OR was elevated significantly for H. pylori–infected subjects carrying the del/del genotype (OR, 4.93; 95% CI, 1.65-14.71). There was an interaction between the −347del/del genotype and H. pylori infection, with the relative excess risk of interaction of 1.68 and a synergy index of 1.67.

Table 3.

The −347 genotype related SGC risk for male subjects from Linqu was associated with H. pylori infection, smoke, and drink status

−347del/A and A/A genotype
−347del/del genotype
No. (SGC/CAG)OR (95% CI)*No. (SGC/CAG)OR (95% CI)*
H. pylori infection     
    Negative 6/18 1.00 8/14 2.00 (0.53-7.61) 
    Positive 20/33 2.35 (0.73-7.54) 42/32 4.93 (1.65-14.71) 
Cigarette smoking     
    No 1/9 1.00 12/7 22.68 (1.85-277.92) 
    Yes 25/42 1.75 (0.49-6.25) 38/39 7.81 (0.92-66.11) 
Alcohol drinking     
    No 4/10 1.00 14/9 3.40 (0.77-15.01) 
    Yes 22/41 1.10 (0.33-3.63) 36/37 2.39 (0.68-8.34) 
−347del/A and A/A genotype
−347del/del genotype
No. (SGC/CAG)OR (95% CI)*No. (SGC/CAG)OR (95% CI)*
H. pylori infection     
    Negative 6/18 1.00 8/14 2.00 (0.53-7.61) 
    Positive 20/33 2.35 (0.73-7.54) 42/32 4.93 (1.65-14.71) 
Cigarette smoking     
    No 1/9 1.00 12/7 22.68 (1.85-277.92) 
    Yes 25/42 1.75 (0.49-6.25) 38/39 7.81 (0.92-66.11) 
Alcohol drinking     
    No 4/10 1.00 14/9 3.40 (0.77-15.01) 
    Yes 22/41 1.10 (0.33-3.63) 36/37 2.39 (0.68-8.34) 
*

OR and 95% CI values were calculated by logistic regression and adjusted for age.

In contrast, among subjects from the low-risk area Beijing, similar correlation was not discovered between these variations and the susceptibility of SGC. Moreover, frequencies of these SNPs were not correlated with various clinical pathologic characteristics such as histotypes, tumor locations, and lymph node/distal metastasis status either (Supplementary Table S3). Somatic mutation was not observed in the gross normal gastric tissues from SGC cases by sequencing of PCR products.

Haplotype Analysis

As all variations were in strong linkage disequilibrium with each other, there were only four common haplotypes (H1-4) with frequency higher than 3.0% among all of the tested cases and controls. Haplotype H4 is the only haplotype that carries −347A and its linked +178C and +234 13N del alleles (the protective alleles for the risk of SGC as shown in Table 2). Borderline significant difference of the frequency of the haplotype H4 [A(−347)-C(−160)-A(−73)-C(+178)-13N del(+234)] was observed between SGC cases and controls among male subjects from Linqu (P = 0.053), which decreased the SGC risk compared with haplotypes carrying −347del, +178T, and +234 13N ins alleles (OR, 0.61; 95% CI, 0.37-1.01; Table 4). Such association could not be observed among females from Linqu and subjects from Beijing (Supplementary Table S4).

Table 4.

Estimated haplotype frequencies of E-cadherin among subjects from Linqu

Five-marker haplotypes*Frequencies (%)
OR (95% CI)
CAGSGC
Male    
    H1 (del-C-A-T-13N ins75 (37.9) 60 (39.5) 1.07 (0.70-1.65) 
    H2 (del-A-A-T-13N ins43 (21.7) 37 (24.3) 1.16 (0.70-1.92) 
    H3 (del-C-C-T-13N ins23 (11.6) 25 (16.4) 1.50 (0.81-2.76) 
    H4 (A-C-A-C-13N del57 (28.8) 30 (19.7) 0.61 (0.37-1.01) 
    All 198 (100.0) 152 (100.0)  
Female    
    H1 (del-C-A-T-13N ins75 (38.7) 13 (32.5) 0.76 (0.37-1.57) 
    H2 (del-A-A-T-13N ins38 (19.6) 11 (27.5) 1.56 (0.71-3.40) 
    H3 (del-C-C-T-13N ins30 (15.5) 4 (10.0) 0.61 (0.20-1.83) 
    H4 (A-C-A-C-13N del51 (26.3) 12 (30.0) 1.20 (0.57-2.54) 
    All 194 (100.0) 40 (100.0)  
Total    
    H1 (del-C-A-T-13N ins150 (38.3) 73 (38.0) 0.99 (0.69-1.41) 
    H2 (del-A-A-T-13N ins81 (20.7) 48 (25.0) 1.28 (0.85-1.93) 
    H3 (del-C-C-T-13N ins53 (13.5) 29 (15.1) 1.14 (0.70-1.86) 
    H4 (A-C-A-C-13N del108 (27.6) 42 (21.9) 0.74 (0.49-1.11) 
    All 392 (100.0) 192 (100.0)  
Five-marker haplotypes*Frequencies (%)
OR (95% CI)
CAGSGC
Male    
    H1 (del-C-A-T-13N ins75 (37.9) 60 (39.5) 1.07 (0.70-1.65) 
    H2 (del-A-A-T-13N ins43 (21.7) 37 (24.3) 1.16 (0.70-1.92) 
    H3 (del-C-C-T-13N ins23 (11.6) 25 (16.4) 1.50 (0.81-2.76) 
    H4 (A-C-A-C-13N del57 (28.8) 30 (19.7) 0.61 (0.37-1.01) 
    All 198 (100.0) 152 (100.0)  
Female    
    H1 (del-C-A-T-13N ins75 (38.7) 13 (32.5) 0.76 (0.37-1.57) 
    H2 (del-A-A-T-13N ins38 (19.6) 11 (27.5) 1.56 (0.71-3.40) 
    H3 (del-C-C-T-13N ins30 (15.5) 4 (10.0) 0.61 (0.20-1.83) 
    H4 (A-C-A-C-13N del51 (26.3) 12 (30.0) 1.20 (0.57-2.54) 
    All 194 (100.0) 40 (100.0)  
Total    
    H1 (del-C-A-T-13N ins150 (38.3) 73 (38.0) 0.99 (0.69-1.41) 
    H2 (del-A-A-T-13N ins81 (20.7) 48 (25.0) 1.28 (0.85-1.93) 
    H3 (del-C-C-T-13N ins53 (13.5) 29 (15.1) 1.14 (0.70-1.86) 
    H4 (A-C-A-C-13N del108 (27.6) 42 (21.9) 0.74 (0.49-1.11) 
    All 392 (100.0) 192 (100.0)  
*

The five markers are −347del>A, −160C>A, −73A>C, +178T>C, and +234CGTGCCCCAGCCC (13N) ins>del.

P = 0.053.

Effect of the −347 Alleles on Promoter Activity

To examine the effect of the −347del and −347A alleles with their linked alleles on transcription of the E-cadherin gene, we analyzed the promoter activity of the H4 and H1 haplotypes (which were different in −347, +178, and +234 sites) using the Dual Luciferase Reporter Assay System in MCF7, MKN74, and HeLa cells. The luciferase activity of the haplotype H4 was lower than that of H1 only in MKN74 cell line but not in MCF7 and HeLa cell lines (Fig. 2).

Figure 2.

Transcriptional activity of the E-cadherin promoter with different haplotypes by the dual-luciferase reporter assay. Each column represents the average value of three parallel wells in the same experiment. The reporter pGL-H1 and pGL-H4 contain promoters with the haplotype H1 (del-C-A-T-13N ins) and H4 (A-C-A-C-13N del), respectively. Data shown are one of two independent experiments.

Figure 2.

Transcriptional activity of the E-cadherin promoter with different haplotypes by the dual-luciferase reporter assay. Each column represents the average value of three parallel wells in the same experiment. The reporter pGL-H1 and pGL-H4 contain promoters with the haplotype H1 (del-C-A-T-13N ins) and H4 (A-C-A-C-13N del), respectively. Data shown are one of two independent experiments.

Close modal

The E-cadherin gene covers an ∼100 kb sequence including 16 exons. A number of polymorphisms and somatic mutations have also been identified within the E-cadherin gene, especially in the coding regions. Several studies showed that genetic variations such as −347del>A and −160C>A of the E-cadherin promoter might affect the susceptibility of SGCs (24-29). Lindstrom et al. (33) once reported a comprehensive study of E-cadherin genetic variants and prostate cancer risk, but only −160C>A polymorphism in the promoter was analyzed. However, the haplotypes and genotypes of the E-cadherin promoter were not studied well yet. In the present study, we analyzed the relationship between the SGC susceptibility and the genotypes and haplotypes of all these variants around the TSS region of E-cadherin, with the largest number of SGC cases investigated thus far from populations with high- and low-SGC risk, respectively.

It was reported that the frequency of the −347A allele was associated with the high risk of familial gastric carcinomas (28 cases and 142 controls) in Korea (23). In contrast, we observed that the −347A allele (and its linked +178T and +234 13N ins alleles) was a protective allele for SGC in Chinese populations because the −347del/del genotype might increase the SGC susceptibility and H. pylori infection elevated this susceptibility for male subjects from the high-risk area Linqu in China (Tables 3 and 4). However, only 76 of the male SGC cases were included in the present study. More investigation is needed to confirm the exact role of these genotypes in the SGC susceptibility.

In addition, all analyzed subjects from Linqu have been enrolled in a >10-year long-term follow-up by gastroendoscopic examination (34). Thus, the important dynamic information of pathologic status of gastric mucosa is available for each subject from Linqu in the present study. We found that the severity of gastric lesions (CAG, IM/DYS, SGC) in males was correlated with the frequency of the −347del/del and its linked genotypes too (Table 2), which suggest that the −347del/del and its linked genotypes may play a role in gastric carcinogenesis through promoting progression of gastric precancerous lesions. However, among females from the same area and subjects from the low-risk area Beijing, such association could not be observed. It is well known that genetic inactivation of E-cadherin by germ line mutations lead to familial diffused gastric carcinomas. However, the frequency of the −347del/del genotype in patients with the intestinal type of SGCs was slightly higher than that in patients with the diffused type of SGCs (68.6% versus 55.6%, not significant). This result was consistent with the possibility that the −347del/del genotype might promote progression of gastric IM/DYS lesions.

Generally, as an “environmental sensor”, a genetically susceptible factor can easily display a role in the development of cancer among subjects under a high pressure of environmental risks. Although the causes for the elevated SGC risk for the residents in Linqu are not clear, a series of studies have identified a number of environmental factors there, including H. pylori infection, high intake of sour pan cakes, salted food, N-nitroso compounds, and low consumption of fresh fruits and vegetables (3, 4, 35). The H. pylori infection was a prevalent event there and an important SGC causal factor for subjects in Linqu (36), which would contribute to a high environmental pressure and enhance the effect of risk factor of −347del/del and its linked genotypes, as we observed in the present study (Table 3). These might account for the fact that the significant risk effect of the −347del allele on SGC could only be observed among subjects from the high-risk area Linqu. Moreover, the incidence of SGC in males is 2-fold of that in females. This might also account for the fact that the role of −347del and its linked alleles could be observed only in males from the high-risk area Linqu, but not in females from the same area. Because of the limited number of female SGC cases (n = 20) diagnosed during the long-term follow-up survey, an additional 92 female SGC cases from Linqu County Hospital were further analyzed to evaluate effect of the −347del/del genotype and female SGC susceptibility (data not shown). Again, no significant correlation was observed. Taken together, these results suggested that the −347del and its linked alleles might be an environment- and sex-dependent genetic risk factor.

There were a number of reports on the association between the −160C>A polymorphism and gastric cancer, but the results were also conflicting (24-29, 37, 38). In the present study, we did not observe any association between −160C>A SNP and the risk of SGC among subjects from both the high-risk area Linqu and the low-risk area Beijing (Table 2; Supplementary Table S1). These results suggested that the −160C>A polymorphism might not contribute to the susceptibility of SGC, at least for residents at Linqu and Beijing. No association was observed between the −73A>C polymorphism and the risk of SGC either.

Here, we also first reported that there is strong linkage disequilibrium between these five observed variants [−347del>A, −160C>A, −73A>C, +178T>C, +234CGTGCCCCAGCCC (13N) ins>del], especially for the −347, +178, and +234 alleles. Thus, four common haplotypes were contributed to >99% of haplotypes of the 1,686 tested subjects, although there should be 25 (64) haplotypes theoretically. In Linqu, the SGC susceptibility–related variant −347del>A links with +178T>C and +234 13N ins>del variants completely. This might account for the fact that only four kinds of haplotypes were detected among 489 tested subjects from the high-risk area. In Beijing, the −347del>A allele strongly links with +178T>C and +234 13N ins>del alleles among 1,185 of 1,197 tested subjects (99.0%). However, this linkage was not observed in 2 SGC cases and 10 control subjects from the low-risk area (Supplementary Table S3). Interestingly, the −347del/del genotype was detected in 14 of the 23 tested cell lines (60.9%), and the linkage between −347del>A and +178T>C and +234 13N ins>del did not exist in seven cell lines (Supplementary Table S2). The ethnic diversity of these cell lines might account for the decreased linkage. The exact biological meanings of this linkage need to be studied further. The protective effect of the −347A containing haplotypes H4 among subjects from Linqu suggests that the strong linkage between these alleles might contribute to the risk of SGCs.

The proximal E-cadherin promoter contains multiple characterized cis-acting elements, such as E-boxes, CAAT box, and GC-rich element (Sp1-binding site), as shown in Fig. 1. It was reported that deletion or mutation of these elements might be detrimental to the activity of the E-cadherin promoter, but deletion of upstream sequences had no effect on promoter activity (39, 40). Shin et al. (23) reported that the −347del allele increased the transcriptional efficiency of E-cadherin in several cell lines (AGS, CV-1, HeLa, KATO-III, and Sun-719) compared with the −347A allele. However, Nakamura et al. (41) reported that variants −347del and −347A displayed the same promoter activity in the CV-1 cell line. The promoter fragment (−647-+147 or −410-+125) they used did not cover the +178 and +234 alleles, which we found linked with the −347 allele almost completely. To elucidate whether the −347 variants affect the promoter activity in their related haplotype patterns, we analyzed the transcription activity of the fragment (−437-+314) covering all these alleles, including the linked +178 and +234 SNPs around the E-cadherin TSS. We did not observe such difference between the most frequent −347del related haplotype H1 [del(−347)-C(−160)-A(−73)-T(+178)-13N ins(+234)] and the low-risk −347A-related haplotype H4 [A(−347)-C(−160)-A(−73)-C(+178)-13N del(+234)] in the MCF7 and HeLa cell lines by the Dual Luciferase Reporter Assay. In contrast, the promoter activity of the −347A haplotype H4 was even significantly lower than that of the H1 in MKN74 cell line (Fig. 2). More study is necessary to illustrate whether different length and localization of tested promoter fragments and transfected cell lines might result in different transcriptional changes in the luciferase promoter activity assay. Alterations of transcriptional activity of promoters with various SNPs by the assay might not always correlate with their contribution to disease susceptibility.

In conclusion, the present study shows that −347 alleles are linked with +178 and +234 alleles almost completely and that the −347del/del and its linked genotypes of E-cadherin may increase the susceptibility of SGC among males in the high-risk area of China.

No potential conflicts of interest were disclosed.

Grant support: Key Technologies and Development Program of China 2002 grant BA711A06 and National Basic Research Program of China grant 2005CB522403.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1
He J, Gu DF, Wu XG, et al. Major causes of death among men and women in China.
N Engl J Med
2005
;
353
:
1124
–34.
2
International Agency for Research on Cancer. Schistosomes, liver flukes, and Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans.
IARC
1994
;
61
:
177
–241.
3
You WC, Zhang L, Gail MH, et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, other risk factors.
J Natl Cancer Inst
2000
;
92
:
1607
–12.
4
Deng DJ. Progress of gastric cancer etiology: N-nitrosamides in the 1990s.
World J Gastroenterol
2000
;
6
:
613
–8.
5
Buiatti E, Munoz N. Chemoprevention of stomach cancer.
IARC Sci Publ
1996
;
136
:
35
–9.
6
Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator.
Science
1991
;
251
:
1451
–5.
7
Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer.
Nature
1998
;
392
:
402
–5.
8
Kaurah P, MacMillan A, Boyd N, et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
JAMA
2007
;
297
:
2360
–72.
9
Becker KF, Atkinson MJ, Reich U, et al. E-Cadherin gene mutations provide clues to diffuse type gastric carcinomas.
Cancer Res
1994
;
54
:
3845
–52.
10
Berx G, Cleton-Jansen AM, Nollet F, et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
EMBO J
1995
;
14
:
6107
–15.
11
Berx G, Becker KF, Hofler H,van Roy F. Mutations of the human E-cadherin (CDH1) gene.
Hum Mutat
1998
;
12
:
226
–37.
12
Ilyas M, Tomlinson IP, Hanby A, Talbot IC, Bodmer WF. Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers.
Gut
1997
;
40
:
654
–9.
13
Wheeler JM, Warren BF, Mortensen NJ, et al. An insight into the genetic pathway of adenocarcinoma of the small intestine.
Gut
2002
;
50
:
218
–23.
14
Mayer B, Johnson JP, Leitl F, et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration.
Cancer Res
1993
;
53
:
1690
–5.
15
Kinsella A, Lepts GC, Hill CL, Jones M. Reduced E-cadherin expression correlates with increased invasiveness in colorectal carcinoma cell lines.
Clin Exp Metastasis
1994
;
12
:
335
–42.
16
Pignatelli M, Ansari TW, Gunter P, et al. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage.
J Pathol
1994
;
174
:
243
–8.
17
Gamallo C, Palacios J, Suarez A, et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma.
Am J Pathol
1993
;
142
:
987
–93.
18
Umbas R, Schalken JA, Aalders TW, et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.
Cancer Res
1992
;
52
:
5104
–9.
19
Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas.
Proc Natl Acad Sci U S A
1995
;
92
:
7416
–9.
20
Machado JC, Oliveira C, Carvalho R, et al. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma.
Oncogene
2001
;
20
:
1525
–8.
21
Batlle E, Sancho E, Franci C, et al. The transition factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells.
Nature Cell Biol
2000
;
2
:
84
–9.
22
Li LC, Chui RM, Sasaki M, et al. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities.
Cancer Res
2000
;
60
:
873
–6.
23
Shin Y, Kim IJ, Kang HC, et al. The E-cadherin -347G→GA promoter polymorphism and its effect on transcriptional regulation.
Carcinogenesis
2004
;
25
:
895
–9.
24
Kuraoka K, Oue N, Yokozaki H, et al. Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumourigenesis and progression of gastric carcinoma in Japan.
Int J Oncol
2003
;
23
:
421
–7.
25
Wu MS, Huang SP, Chang YT, et al. Association of the -160C→A promoter polymorphism of E-cadherin gene with gastric carcinoma risk.
Cancer
2002
;
94
:
1443
–8.
26
Humar B, Graziano F, Cascinu S, et al. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer.
Oncogene
2002
;
21
:
8192
–5.
27
Park WS, Cho YG, Park JY, et al. A single nucleotide polymorphism in the E-cadherin gene promoter-160 is not associated with risk of Korean gastric cancer.
J Korean Med Sci
2003
;
18
:
501
–4.
28
Lu Y, Xu YC, Shen J, et al. E-cadherin gene C-160A promoter polymorphism and risk of non-cardia gastric cancer in a Chinese population.
World J Gastroenterol
2005
;
11
:
56
–60.
29
Pharoah PD, Oliveira C, Machado JC, et al. CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancer.
Int J Cancer
2002
;
101
:
196
–7.
30
You WC, Blot WJ, Li JY, et al. Precancerous gastric lesions in a population at high risk of stomach cancer.
Cancer Res
1993
;
53
:
1371
–21.
31
Zhang L, Blot WJ, You WC, et al. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
Cancer Epidemiol Biomarker Prev
1996
;
5
:
627
–30.
32
Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci.
Cell Res
2005
;
15
:
97
–8.
33
Lindstrom S, Wiklund F, Jonsson BA, et al. Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk: strong confirmation of functional promoter SNP.
Hum Genet
2005
;
118
:
339
–47.
34
You WC, Li JY, Blot WJ, et al. Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer.
Int J Cancer
1999
;
83
:
615
–9.
35
You WC, Blot WJ, Chang YS, et al. Diet and high risk of stomach cancer in Shandong, China.
Cancer Res
1988
;
48
:
3518
–23.
36
You W, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
J Natl Cancer Inst
2006
;
98
:
974
–83.
37
Song CG, Huang CM, Liu X, et al. Association of −160C>A polymorphism in CDH1 gene with gastric cancer risk in Fujian Chinese population.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
2005
;
22
:
557
–9.
38
Zhang XF, Wang YM, Wang R, et al. Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardia adenocarcinoma.
Ai Zheng
2005
;
24
:
513
–9.
39
Hajra KM, Ji X, Fearon ER. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements.
Oncogene
1999
;
18
:
7274
–9.
40
Hajra KM, Chen DY-S, Fearon ER. The Slug zinc-finger protein represses E-cadherin in breast cancer.
Cancer Res
2002
;
62
:
1613
–8.
41
Nakamura A, Shimazaki T, Kaneko K, et al. Characterization of DNA polymorphisms in the E-cadherin gene (CDH1) promoter region.
Mutat Res
2002
;
502
:
19
–24.

Supplementary data